Scholars Central

OpinionPublished 30 Jun 2021

Hereditary profiling of CLL: a 'TP53 fiend' opinion

Authors: Kritika Kundaliya

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Chronic Lymphocytic Leukemia (CLL) is a B-cell danger with an exceptionally factor clinical course. While a few patients require treatment moderately before long determination, others may stay liberated from side effects for a long time with a standard ‘observe furthermore, stand by’ reconnaissance approach.

Subjects

Haematology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Hematology and Clinical Therapeutics.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Hematology and Clinical Therapeutics
  • SubjectHaematology
  • BylineArticles whose byline prints “Kritika Kundaliya”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels